Global Farma Titularidad de Registros DIGEMID vs bioaccess® LATAM Market Access

Global Farma vs bioaccess®: what Global Farma publishes, and when a one-country or dossier partner is enough versus the bioaccess® registration holder across Latin America.

Global Farma shows up when manufacturers search for a Latin American registration holder or sanitary-registration partner. This article uses only what Global Farma publishes on its own site (globalfarma.pe/services/titularidad-de-registros), then compares it with the multi-country subscription from bioaccess®. It is a practitioner comparison, not a teardown.

What Global Farma publishes

Global Farma is a Peruvian company whose titularidad de registros page offers to hold registrations for pharmaceuticals, cosmetics, medical devices and sanitary products, and to import through its own droguería.

Global Farma vs bioaccess®

Dimension Global Farma bioaccess®
Public product DIGEMID registration holder + import through its droguería LATAM medical device registration: registration, in-country holder, certified translations, government fees up to a stated cap, tecnovigilancia (import shipments quoted separately)
Geography Peru 19 LATAM markets
Public pricing None published Published two-part pricing: a one-time registration fee by country and class, plus an annual holder fee from year 2 (rate card)
Holder vs distributor Acts as the titular responsible before DIGEMID and imports through its own droguería Holds through its own in-country entities, with defined transfer provisions; the registration is never leverage
Bridge from a clinical trial None published Trial-to-Market continuity: the same partner that ran your FIH study can carry registration (see market access)

Where each one fits

If Peru is the only market and you want the titular and the importing droguería in one local company, Global Farma covers it.

The LATAM medical device registration service from bioaccess® is a different product. bioaccess® registers already FDA-cleared or CE-marked devices and holds them through its own in-country entities across 19 Latin American markets, including COFEPRIS, ANVISA, INVIMA, ANMAT, ISP and DIGEMID. Pricing is published as two parts: a one-time registration fee by country and device class, plus an annual holder fee from year 2 (see the rate card). Initial government fees and certified translations are included up to a stated cap, and the first 12 months of holder service are included (importer-of-record shipments are priced separately on the hub). For multi-country pricing, contact us or see the rate card. The registration is held for the manufacturer’s benefit, with defined transfer provisions if you ever change partners or set up your own entity.

One country and one local partner is enough? Hire the firm that publishes that job. Several LATAM labels under one holder who is not your distributor? Start at bioaccess® market access, read the LATAM importer of record guide, try the LATAM Launch Calculator, or request a registration quote.

Competitor facts from the Global Farma public pages linked above, reviewed for bioaccess® competitive research (Aug 2026–Nov 2026). Claims are theirs. No invented clients, prices or contacts.

← Back to Blog · Contact bioaccess®